Cargando…
Translating “Big Data” in Oncology for Clinical Benefit: Progress or Paralysis
The molecular characterization of cancer through genomics, data from multiomics technologies, molecular-driven clinical trials, and internet-enabled devices capturing patient context and real-world data are creating an unprecedented big data revolution across the cancer research-care continuum. Whil...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Association for Cancer Research
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306452/ https://www.ncbi.nlm.nih.gov/pubmed/35416976 http://dx.doi.org/10.1158/0008-5472.CAN-22-0100 |